Wagner Charles F Jr's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Mar 14, 2023
- Accession no.
- 0001209191-23-018460
- Filed
- Mar 14, 2023
- Trade date
- Mar 10-13, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 14 non-derivative transactions. Open-market sales total $1.39M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wagner Charles F JrCIK 0001223348 | Officer (EVP & Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2023 | Common Stock | SSaleDisposed | −361 | $286.64F2,F3 | −$103,477.04 | 57,772 | Direct | |
| Mar 10, 2023 | Common Stock | SSaleDisposed | −515 | $287.83F2,F4 | −$148,232.45 | 57,257 | Direct | |
| Mar 10, 2023 | Common Stock | SSaleDisposed | −327 | $288.91F2,F5 | −$94,473.57 | 56,930 | Direct | |
| Mar 10, 2023 | Common Stock | SSaleDisposed | −30 | $289.44 | −$8,683.2 | 56,900 | Direct | |
| Mar 10, 2023 | Common Stock | SSaleDisposed | −541 | $291.47F2,F6 | −$157,685.27 | 56,359 | Direct | |
| Mar 10, 2023 | Common Stock | SSaleDisposed | −185 | $292.68F2,F7 | −$54,145.8 | 56,174 | Direct | |
| Mar 10, 2023 | Common Stock | SSaleDisposed | −27 | $293.61 | −$7,927.47 | 56,147 | Direct | |
| Mar 10, 2023 | Common Stock | SSaleDisposed | −102 | $294.94F2,F8 | −$30,083.88 | 56,045 | Direct | |
| Mar 13, 2023 | Common Stock | SSaleDisposed | −24 | $288.31 | −$6,919.44 | 56,021 | Direct | |
| Mar 13, 2023 | Common Stock | SSaleDisposed | −420 | $292.41F2,F9 | −$122,812.2 | 55,061 | Direct | |
| Mar 13, 2023 | Common Stock | SSaleDisposed | −1,153 | $293.35F2,F10 | −$338,232.55 | 54,448 | Direct | |
| Mar 13, 2023 | Common Stock | SSaleDisposed | −715 | $294.52F2,F11 | −$210,581.8 | 53,733 | Direct | |
| Mar 13, 2023 | Common Stock | SSaleDisposed | −292 | $295.89F2,F12 | −$86,399.88 | 53,441 | Direct | |
| Mar 13, 2023 | Common Stock | SSaleDisposed | −62 | $296.77 | −$18,399.74 | 53,379 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 10 transactions in Table I.
- F3
Open market sales reported on this line occurred at a weighted average price of $286.64 (range $286.17 to $287.16).
Referenced by the price of 1 transaction in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $287.83 (range $287.30 to $288.20).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $288.91 (range $288.37 to $289.34).
Referenced by the price of 1 transaction in Table I.
- F6
Open market sales reported on this line occurred at a weighted average price of $291.47 (range $291.10 to $292.00).
Referenced by the price of 1 transaction in Table I.
- F7
Open market sales reported on this line occurred at a weighted average price of $292.68 (range $292.14 to $293.12).
Referenced by the price of 1 transaction in Table I.
- F8
Open market sales reported on this line occurred at a weighted average price of $294.94 (range $294.85 to $295.35).
Referenced by the price of 1 transaction in Table I.
- F9
Open market sales reported on this line occurred at a weighted average price of $292.41 (range $291.97 to $292.82).
Referenced by the price of 1 transaction in Table I.
- F10
Open market sales reported on this line occurred at a weighted average price of $293.35 (range $292.99 to $293.80).
Referenced by the price of 1 transaction in Table I.
- F11
Open market sales reported on this line occurred at a weighted average price of $294.52 (range $294.13 to $294.81).
Referenced by the price of 1 transaction in Table I.
- F12
Open market sales reported on this line occurred at a weighted average price of $295.89 (range $295.33 to $296.32).
Referenced by the price of 1 transaction in Table I.